Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

NEO-CORTEF

HYDROCORTISONE ACETATE; NEOMYCIN SULFATE

Standard Dose
1.5%;EQ 3.5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEO-CORTEF is listed in Drugs@FDA under application 060612 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCORTISONE ACETATE; NEOMYCIN SULFATE Form and strength SUSPENSION/DROPS;OPHTHALMIC - 1.5%;EQ 3.5MG BASE/ML Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NEO-CORTEF is listed in Drugs@FDA under application 060612 (ANDA). Marketing status: Discontinued Active ingredient HYDROCORTISONE ACETATE; NEOMYCIN SULFATE Form and strength SUSPENSION/DROPS;OPHTHALMIC - 1.5%;EQ 3.5MG BASE/ML Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.